Altre lingue Item 9 Labs Corp.

Azioni

INLB

US46564C2035

Mercato chiuso - OTC Markets Altri mercati azionari 18:13:40 06/05/2024			Variaz. 5gg	Var. 1 gen.
0,0001 ^USD	-50,00%		0,00%	-94,74%

2023	Articolo 9 Labs Corp. Riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 giugno 2023	CI
2023	Douglas Bowden si è dimesso da Presidente del Consiglio di Amministrazione di Item 9 Labs Corp, con effetto dal 18 luglio 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Item 9 Labs Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	21/08/23
Item 9 Labs : Bankruptcy - Form 8-K	20/07/23
Douglas Bowden Resigned as Chairman of the Board of Directors of Item 9 Labs Corp, Effective July 18, 2023	20/07/23
Douglas Bowden Resign as Interim CEO of Item 9 Labs Corp	20/07/23
Item 9 Labs Corp. Announces Resignation of Shane Evans as A Member of the Board of Directors	27/06/23
Item 9 Labs Corp. cancelled the acquisition of Sessions Cannabis from Steven Fry, Najla Guthrie, Darryl Allen, Louis Laskovski, 2628146 Ontario Ltd. and 11949896 Canada Inc.	25/05/23
Item 9 Labs Corp. Executes Major Restructuring to Pave the Way to Profitability	23/05/23
Item 9 Labs Corp. Announces Management Changes	23/05/23
Item 9 Labs Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	22/05/23
ITEM 9 LABS CORP. - 8-K - LABS CORP. : Change in Directors or Principal Officers, Other Events (form 8-K)	22/05/23
Item 9 Labs Corp. Announces Resignation of Michael Weinberger as Member of the Board of Directors	22/05/23
Item 9 Labs Corp. Announces CEO Changes	22/05/23
Item 9 Labs Corp. Announces the Resignation of Lawrence X. Taylor as Board of Director	12/05/23
Item 9 Labs Releases Latest Limited Edition One-Gram Rosin-Infused Pre-Rolls	10/05/23
Item 9 Labs Releases Latest Limited Edition One-Gram Rosin-Infused Pre-Rolls	10/05/23
ITEM 9 LABS CORP. - 8-K - LABS CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities (form 8-K)	05/05/23
Notice to the Annual General Meeting of MilDef Group AB (publ)	24/04/23
Unity Rd. To Exhibit at 2023 Multi-Unit Franchising Conference	13/04/23
Item 9 Labs Corp. To Present at the Benzinga Spring Cannabis Capital Conference	06/04/23
Item 9 Labs : Accelaration/Increase of Financial Obligation - Form 8-K	05/04/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Item 9 Labs Corp.

Azioni

INLB

US46564C2035

Altre lingue

Filtri